Income Tax Expense (Benefit) of Enveric Biosciences, Inc. from 30 Jun 2010 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Enveric Biosciences, Inc. annual and quarterly Income Tax Expense (Benefit) in USD history and change rate from 30 Jun 2010 to 31 Dec 2024.
Enveric Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $1,731.
Enveric Biosciences, Inc. annual Income Tax Expense (Benefit) for 2024 was $8,930, a 69% decline from 2023.
Enveric Biosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $28,913.
Enveric Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $1,486.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Change (%)

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Change (%)

Enveric Biosciences, Inc. Annual Income Tax Expense (Benefit) (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$8,930	-$19,983	-69%	01 Jan 2024	31 Dec 2024	10-K	28 Mar 2025	2024	FY
2023	$28,913	+$30,399		01 Jan 2023	31 Dec 2023	10-K	28 Mar 2025	2024	FY
2022	$1,486	+$7,453,319		01 Jan 2022	31 Dec 2022	10-K	26 Mar 2024	2023	FY
2021	$7,454,805^*			01 Jan 2021	31 Dec 2021	10-K/A	09 Jun 2023	2022	FY
2019	$388,657	-$5,959,845		01 Jan 2019	31 Dec 2019	10-K/A	12 Aug 2020	2019	FY
2018	$6,348,502^*	+$8,740,264		01 Jan 2018	31 Dec 2018	10-K/A	12 Aug 2020	2019	FY
2017	$2,391,762^*	+$1,356,084		01 Jan 2017	31 Dec 2017	10-K	26 Mar 2019	2018	FY
2016	$3,747,846^*	-$3,619,386		01 Jan 2016	31 Dec 2016	10-K	02 Apr 2018	2017	FY
2015	$128,460	-$129,293	-15521%	01 Jan 2015	31 Dec 2015	10-K/A	04 Apr 2017	2016	FY
2014	$833	-$617	-43%	01 Jan 2014	31 Dec 2014	10-K	31 Mar 2015	2014	FY
2013	$1,450	-$481	-25%	01 Jan 2013	31 Dec 2013	10-K	31 Mar 2015	2014	FY
2012	$1,931	-$54	-2.7%	01 Jan 2012	31 Dec 2012	10-K	28 Mar 2014	2013	FY
2011	$1,985	-$1,581	-44%	01 Jan 2011	31 Dec 2011	10-K	28 Feb 2013	2012	FY
2010	$3,566			01 Jan 2010	31 Dec 2010	10-K	07 Mar 2012	2011	FY

Enveric Biosciences, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024		$1,731			01 Jan 2024	31 Mar 2024	10-Q	14 May 2025	2025	Q1
Q3 2023		$6,595			01 Jul 2023	30 Sep 2023	10-Q	14 Nov 2024	2024	Q3
Q3 2020	$415,865	$27,857	-$26,790	-2511%	01 Jul 2020	30 Sep 2020	10-Q	16 Nov 2020	2020	Q3
Q2 2020	$442,655	$17,485	+$895	+5.4%	01 Apr 2020	30 Jun 2020	10-Q	14 Aug 2020	2020	Q2
Q1 2020	$441,760	$21,892	+$53,103		01 Jan 2020	31 Mar 2020	10-Q	15 May 2020	2020	Q1
Q4 2019	$388,657	$404,345			01 Oct 2019	31 Dec 2019	10-K/A	12 Aug 2020	2019	FY
Q3 2019		$1,067	-$26,001	-104%	01 Jul 2019	30 Sep 2019	10-Q	16 Nov 2020	2020	Q3
Q2 2019		$16,590	+$16,590		01 Apr 2019	30 Jun 2019	10-Q	14 Aug 2020	2020	Q2
Q1 2019		$31,211	-$31,211		01 Jan 2019	31 Mar 2019	10-Q	15 May 2020	2020	Q1
Q3 2018		$24,934	+$24,934		01 Jul 2018	30 Sep 2018	10-Q	08 Nov 2019	2019	Q3
Q2 2018		$0	$0		01 Apr 2018	30 Jun 2018	10-Q	14 Aug 2019	2019	Q2
Q1 2018		$0	$0		01 Jan 2018	31 Mar 2018	10-Q	14 May 2019	2019	Q1
Q3 2017		$0	$0		01 Jul 2017	30 Sep 2017	10-Q	14 Nov 2018	2018	Q3
Q2 2017		$0	$0		01 Apr 2017	30 Jun 2017	10-Q	14 Aug 2018	2018	Q2
Q1 2017		$0	-$2,020	-100%	01 Jan 2017	31 Mar 2017	10-Q	15 May 2018	2018	Q1
Q3 2016	$41,744	$0	+$128,460		01 Jul 2016	30 Sep 2016	10-Q	13 Nov 2017	2017	Q3
Q2 2016	$170,204	$0	-$43,489	-100%	01 Apr 2016	30 Jun 2016	10-Q	14 Aug 2017	2017	Q2
Q1 2016	$126,715	$2,020	+$1,745	+635%	01 Jan 2016	31 Mar 2016	10-Q/A	15 May 2017	2017	Q1
Q4 2015	$128,460	$43,764	+$113,987	+72%	01 Oct 2015	31 Dec 2015	10-K/A	04 Apr 2017	2016	FY
Q3 2015	$242,447	$128,460	-$128,525	-197731%	01 Jul 2015	30 Sep 2015	10-Q	14 Nov 2016	2016	Q3
Q2 2015	$113,922	$43,489	-$114,747	-73%	01 Apr 2015	30 Jun 2015	10-Q	12 Aug 2016	2016	Q2
Q1 2015	$825	$275	-$8	-2.8%	01 Jan 2015	31 Mar 2015	10-Q	14 May 2015	2015	Q1
Q4 2014	$833	$157,751	-$159,201	-10979%	01 Oct 2014	31 Dec 2014	10-K	31 Mar 2015	2014	FY
Q3 2014	$160,034	$65	+$65		01 Jul 2014	30 Sep 2014	10-Q	14 Nov 2014	2014	Q3
Q2 2014	$159,969	$158,236	+$158,236		01 Apr 2014	30 Jun 2014	10-Q	18 Aug 2015	2015	Q1
Q1 2014	$1,733	$283	+$283		01 Jan 2014	31 Mar 2014	10-Q	14 May 2015	2015	Q1
Q4 2013	$1,450	$1,450	-$181	-11%	01 Oct 2013	31 Dec 2013	10-K	31 Mar 2015	2014	FY
Q3 2013	$1,631	$0	-$300	-100%	01 Jul 2013	30 Sep 2013	10-Q	14 Nov 2014	2014	Q3
Q2 2013	$1,931	$0	$0		01 Apr 2013	30 Jun 2013	10-Q	11 Aug 2014	2014	Q2
Q1 2013	$1,931	$0	$0		01 Jan 2013	31 Mar 2013	10-Q	02 May 2013	2013	Q1
Q4 2012	$1,931	$1,631	-$354	-18%	01 Oct 2012	31 Dec 2012	10-K	28 Mar 2014	2013	FY
Q3 2012	$2,285	$300	+$300		01 Jul 2012	30 Sep 2012	10-Q	06 Nov 2013	2013	Q3
Q2 2012	$1,985	$0	$0		01 Apr 2012	30 Jun 2012	10-Q	01 Aug 2013	2013	Q2
Q1 2012	$1,985	$0	$0		01 Jan 2012	31 Mar 2012	10-Q	02 May 2013	2013	Q1
Q4 2011	$1,985	$1,985			01 Oct 2011	31 Dec 2011	10-K	28 Feb 2013	2012	FY
Q3 2011		$0	$0		01 Jul 2011	30 Sep 2011	10-Q	14 Nov 2011	2011	Q3
Q2 2011		$0	$0		01 Apr 2011	30 Jun 2011	10-Q	01 Aug 2012	2012	Q2
Q1 2011		$0			01 Jan 2011	31 Mar 2011	10-Q/A	10 May 2012	2012	Q1
Q3 2010		$0			01 Jul 2010	30 Sep 2010	10-Q	14 Nov 2011	2011	Q3
Q2 2010		$0			01 Apr 2010	30 Jun 2010	10-Q	02 Aug 2011	2011	Q2

* An asterisk sign (*) next to the value indicates that the value is likely invalid.